(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2024-04-22 View latest technical analysis
10 day averaged volume of Biomarin Pharmaceutical is 1662780
| Date | Daily Closing Price | Open | High | Low | Volume |
| 22 Mon Apr 2024 | 89.49 | 89.46 | 89.81 | 88.89 | 0.756 times |
| 19 Fri Apr 2024 | 88.63 | 89.67 | 90.18 | 88.29 | 1.07 times |
| 18 Thu Apr 2024 | 90.07 | 90.25 | 91.21 | 89.78 | 0.568 times |
| 17 Wed Apr 2024 | 90.47 | 91.14 | 91.53 | 90.02 | 0.771 times |
| 16 Tue Apr 2024 | 90.87 | 90.93 | 91.78 | 90.16 | 0.743 times |
| 15 Mon Apr 2024 | 91.51 | 92.58 | 93.36 | 90.96 | 1.168 times |
| 12 Fri Apr 2024 | 92.22 | 91.26 | 93.26 | 91.09 | 1.455 times |
| 11 Thu Apr 2024 | 91.46 | 90.99 | 91.59 | 89.33 | 1.381 times |
| 10 Wed Apr 2024 | 90.21 | 88.38 | 90.41 | 87.79 | 1.326 times |
| 09 Tue Apr 2024 | 88.98 | 87.35 | 89.19 | 87.35 | 0.709 times |
My analysis of stock is bullish for shortterm, and stock might move up till 90.6 or till 92.8. Use a stoploss of 88.8 and if this stock hits its stoploss, then it can fall down till 86.98
Share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Target | 83.44 |
| Downside Target | 88.89 |
| Upside Target | 89.76 |
| Upside Target | 89.81 |
| Upside Target | 93.26 |
| Upside Target | 93.36 |
| Upside Target | 94.15 |
| Upside Target | 99.25 |
| Upside Target | 99.56 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Intraday Target | 88.98 |
| Downside Intraday Target | 88.48 |
| Upside Intraday Target | 89.9 |
| Upside Intraday Target | 90.32 |
| Downside Intraday Target | 89.4 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 22 Mon Apr 2024 | 89.49 | 89.46 | 89.81 | 88.89 | 0.175 times |
| 19 Fri Apr 2024 | 88.63 | 92.58 | 93.36 | 88.29 | 0.761 times |
| 12 Fri Apr 2024 | 92.22 | 87.00 | 93.26 | 86.95 | 1.791 times |
| 05 Fri Apr 2024 | 86.95 | 86.98 | 88.13 | 85.62 | 1.095 times |
| 28 Thu Mar 2024 | 87.34 | 84.70 | 88.74 | 84.70 | 0.895 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 22 Mon Apr 2024 | 89.49 | 86.98 | 93.36 | 85.62 | 0.95 times |
| 28 Thu Mar 2024 | 87.34 | 86.39 | 88.74 | 83.44 | 0.754 times |
| 29 Thu Feb 2024 | 86.28 | 87.72 | 94.15 | 85.60 | 1.241 times |
| 31 Wed Jan 2024 | 88.08 | 96.45 | 99.25 | 87.63 | 0.726 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term and the buy signal is strong.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Biomarin Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 90.58 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term and the buy signal is strong.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Biomarin Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 90.58 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.